HF
MGRX icon

HRT Financial’s Mangoceuticals MGRX Stock Holding History

HRT Financial’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13K Buy
+36,003
New +$13.9K ﹤0.01% 3964
2025
Q1 		– Sell
-13,472
Closed -$32K – 3046
2024
Q4 		$32K Buy
+13,472
New +$35.3K ﹤0.01% 2155

Other funds holding MGRX

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
ACA
Ackerman Capital Advisors Dallas, Texas $497M AUM 16.31% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

HRT Financial's MGRX Position: Q2 2026 in Review

HRT Financial opened a new position in Mangoceuticals (MGRX) in Q2 2026: 36,003 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #3964 among its holdings. This is a return to the name: HRT Financial previously reported a position in MGRX as recently as Q4 2024.

HRT Financial first reported a position in MGRX in Q4 2024 and has held it in 2 quarters since. The position peaked at $32K in Q4 2024. 18 funds tracked by Wall St. Rank hold MGRX as of Q2 2026.

  • HRT Financial held 36,003 shares of Mangoceuticals worth $13K as of Q2 2026.
  • Mangoceuticals was a new HRT Financial position in Q2 2026.
  • Mangoceuticals made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3964 holding.
  • HRT Financial first reported a position in Mangoceuticals in Q4 2024 and has held it in 2 quarters since.
  • HRT Financial's Mangoceuticals position peaked at $32K in Q4 2024.
  • 18 funds tracked by Wall St. Rank held Mangoceuticals as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.